Clinical Trial: Neoadjuvant presurgical Becotatug vedotin (MRG003) Plus Pucotenlimab (HX008) in oral cavity squamous cell carcinomaA Phase 2 Open-Label Clinical Trial (China)

China, Aug. 17 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Neoadjuvant presurgical Becotatug vedotin (MRG003) Plus Pucotenlimab (HX008) in oral cavity squamous cell carcinomaA Phase 2 Open-Label Clinical Trial'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130137

Registration Time: 2026/08/15

Type: Interventional study

Primary Sponsor: Sun Yat-sen University Cancer Center

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=336290

Published by HT Digital Content Services with permission from Health Daily Digest....